Biofrontera Inc. (BFRI)
USD 0.72
(4.33%)
USD 0.72
(4.33%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.39 Million USD | 301.11% |
| 2022 | 1.34 Million USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 38.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.44 Million USD | -80.1% |
| 2024 Q1 | 7.23 Million USD | 34.02% |
| 2023 Q4 | 5.39 Million USD | 91.86% |
| 2023 FY | 5.39 Million USD | 301.11% |
| 2023 Q3 | 2.81 Million USD | 28.2% |
| 2023 Q2 | 2.19 Million USD | 81.56% |
| 2023 Q1 | 1.2 Million USD | -10.18% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 1.34 Million USD | 0.0% |
| 2022 Q4 | 1.34 Million USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2020 FY | - USD | -100.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 38.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 98.288% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 94.537% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 99.199% |
| Cosmos Health Inc. | 12.42 Million USD | 56.544% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -422.594% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 99.002% |
| Cronos Group Inc. | 2.53 Million USD | -112.564% |
| Incannex Healthcare Limited | 373 Thousand USD | -1347.453% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 85.136% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 95.858% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -8927.371% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -720.885% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -720.885% |
| SCYNEXIS, Inc. | 15.08 Million USD | 64.198% |
| Safety Shot Inc | 1.54 Million USD | -248.553% |
| Theratechnologies Inc. | 58.96 Million USD | 90.844% |
| Alpha Teknova, Inc. | 30.45 Million USD | 82.274% |
| Universe Pharmaceuticals INC | 5.48 Million USD | 1.522% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 99.079% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -787.993% |
| Dynavax Technologies Corporation | 256.91 Million USD | 97.899% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 99.245% |
| Radius Health, Inc. | 365.31 Million USD | 98.522% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -103.932% |
| Alvotech | 1.07 Billion USD | 99.498% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 68.125% |
| SIGA Technologies, Inc. | 1.46 Million USD | -268.782% |
| Shineco, Inc. | 29.65 Million USD | 81.795% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Journey Medical Corporation | 17.73 Million USD | 69.549% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | 34.768% |
| Embecta Corp. | 1.63 Billion USD | 99.67% |
| Harrow Health, Inc. | 190.5 Million USD | 97.166% |
| Procaps Group, S.A. | 285.93 Million USD | 98.112% |
| DURECT Corporation | 20.74 Million USD | 73.976% |
| PainReform Ltd. | 86 Thousand USD | -6177.907% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 86.999% |
| OptiNose, Inc. | 131.74 Million USD | 95.902% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -360.27% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 95.476% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 70.703% |
| ProPhase Labs, Inc. | 21.38 Million USD | 74.747% |
| Phibro Animal Health Corporation | 525.45 Million USD | 98.973% |
| Procaps Group S.A. | 285.93 Million USD | 98.112% |
| TherapeuticsMD, Inc. | 8 Million USD | 32.555% |
| Viatris Inc. | 18.12 Billion USD | 99.97% |
| Rockwell Medical, Inc. | 13.43 Million USD | 59.826% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 64.314% |
| Tilray Brands, Inc. | 387.31 Million USD | 98.606% |
| PetIQ, Inc. | 468.3 Million USD | 98.847% |
| Talphera, Inc. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 98.74% |
| Alimera Sciences, Inc. | 67.39 Million USD | 91.989% |
| Assertio Holdings, Inc. | 40.91 Million USD | 86.803% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -396.371% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 84.742% |
| Hempacco Co., Inc. | 13.72 Million USD | 60.662% |
| Alvotech | 1.07 Billion USD | 99.498% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 99.125% |
| Kamada Ltd. | 8.74 Million USD | 38.29% |
| Currenc Group, Inc. | 31.94 Million USD | 83.098% |
| Indivior PLC | 281.6 Million USD | 98.083% |
| Evoke Pharma, Inc. | 5 Million USD | -7.98% |
| Flora Growth Corp. | 3.67 Million USD | -47.032% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -422.594% |
| Evolus, Inc. | 126.54 Million USD | 95.734% |
| HUTCHMED (China) Limited | 86.13 Million USD | 93.732% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 99.134% |
| Akanda Corp. | 3.99 Million USD | -35.016% |